Table 2 Adjusted relative risk (95% CI) per 100 kJ m−2 increase in total erythemal UVR dose during early life for type 1 diabetes developed by age 16 years in children born in Western Australia between 1980–2014.
Combined | Boys | Girls | ||||
|---|---|---|---|---|---|---|
Relative riska (95% CI) | p value | Relative riska (95% CI) | p value | Relative riska (95% CI) | p value | |
First trimester | 0.97 (0.88, 1.07) | 0.52 | 0.92 (0.80, 1.06) | 0.25 | 1.01 (0.88, 1.16) | 0.87 |
Second trimester | 0.97 (0.89, 1.05) | 0.40 | 0.95 (0.85, 1.06) | 0.34 | 0.98 (0.88, 1.10) | 0.76 |
Third trimester | 0.86 (0.76, 0.98) | 0.02 | 0.80 (0.67, 0.95) | 0.01 | 0.95 (0.79, 1.13) | 0.57 |
Gestation periodb | 0.95 (0.90, 1.00) | 0.05 | 0.92 (0.85, 0.99) | 0.02 | 0.98 (0.91, 1.05) | 0.60 |
0–3 months | 0.82 (0.70, 0.96) | 0.01 | 0.71 (0.56, 0.90) | 0.004 | 0.93 (0.75, 1.15) | 0.51 |
3–6 months | 0.81 (0.70, 0.95) | 0.01 | 0.75 (0.60, 0.94) | 0.01 | 0.89 (0.71, 1.10) | 0.27 |
6–9 months | 0.83 (0.70, 0.97) | 0.01 | 0.76 (0.61, 0.95) | 0.02 | 0.90 (0.72, 1.12) | 0.34 |
9–12 months | 0.84 (0.72, 0.96) | 0.03 | 0.76 (0.60, 0.96) | 0.02 | 0.93 (0.75, 1.16) | 0.34 |
First year of life | 0.95 (0.91, 0.99) | 0.01 | 0.92 (0.86, 0.98) | 0.01 | 0.97 (0.92, 1.03) | 0.37 |